Artelo Biosciences terminates ATM offering agreement with R.F. Lafferty; minimal prior sales

ARTELO BIOSCIENCES, INC.

Termination notice issued May 11, 2026; effective May 18, 2026.
Agreement allowed up to $6.5M in common stock sales; only 50,858 shares sold for $451,527 gross proceeds.
ATM program was entered July 18, 2025 and never significantly utilized.

item 1.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.